ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a real-world optical coherence tomography (OCT) imaging study of coronary OAS patients were released at EuroPCR 2021. […]
Tag: Cardiovascular System
Cardiovascular Systems, Inc. Announces Partnership With Chansu Vascular Techologies, LLC to Develop New Drug-Coated Balloon Technology
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and coronary everolimus drug-coated balloons (DCBs). This partnership brings together CSI’s leadership in the treatment of calcified arterial lesions with Dr. Philippe Marco, a pioneer […]
Cardiovascular Systems, Inc. Reports Fiscal 2020 Third-Quarter Financial Results
05/05/20 Conference Call Scheduled for Today, May 5, 2020, at 3:30 PM CT (4:30 PM ET) Healthcare system response to COVID-19 pandemic delayed atherectomy procedures and negatively impacted third quarter results Revenues of $61.2 million decreased 3.4% from third quarter last year Net loss was $2.9 million, or $0.08 per […]